2OIP | A:3-180; B:3-180; C:3-180; D:3-180; E:3-180 | CRYSTAL STRUCTURE OF THE S290G ACTIVE SITE MUTANT OF TS-DHFR FROM CRYPTOSPORIDIUM HOMINIS |
3DL5 | A:3-180; B:3-180; C:3-180; D:3-180; E:3-180 | CRYSTAL STRUCTURE OF THE A287F ACTIVE SITE MUTANT OF TS-DHFR FROM CRYPTOSPORIDIUM HOMINIS |
3HJ3 | A:3-180; B:3-180; C:3-180; D:3-178 | CRYSTAL STRUCTURE OF THE CHTS-DHFR F207A NON-ACTIVE SITE MUTANT |
4KY8 | A:3-178; B:3-178; C:3-178; D:3-178; E:3-178 | CRYSTAL STRUCTURE OF TS-DHFR FROM CRYPTOSPORIDIUM HOMINIS IN COMPLEX WITH NADPH, METHOTREXATE, FDUMP AND 4-((2-AMINO-6-METHYL-4-OXO-4,7-DIHYDRO-3H-PYRROLO[2,3-D]PYRIMIDIN-5-YL)THIO)-2-CHLOROPHENYL)-L-GLUTAMIC ACID |